Effective Delivery of Apomorphine in the Management of Parkinson Disease
Authors:
- Roongroj BhidayasiriRBRoongroj Bhidayasiri
- K. Ray ChaudhuriK. Ray Chaudhuri
- Peter LeWittPLPeter LeWitt
- Anne MartinAMAnne Martin
- Kamolwan BoonpangKBKamolwan Boonpang
- Teus van LaarTLTeus van Laar
- 1 May 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 38 (3) , 89-103
Abstract
The clinical utility of long-term oral levodopa therapy in Parkinson disease (PD) is often limited by the emergence of motor complications. Over time, many patients with PD experience regular and/or unpredictable “off” periods, despite taking optimized oral medication regimens, with a major negative impact on their ability to undertake routine activities of daily living and consequently on their overall quality of life. One established approach for treating patients experiencing off periods and controlling motor fluctuations refractory to conventional oral drug therapy is the subcutaneous administration of the dopaminergic agonist apomorphine. This article outlines how the pharmacokinetic properties of apomorphine underpin its efficacy for the treatment of PD and provides practical guidance for the 3 main approaches in which it is used: subcutaneous intermittent apomorphine injection as a “rescue” therapy for off states, subcutaneous continuous apomorphine infusion for PD patients with intractable motor fluctuations as an alternative to other dopaminergic treatment, and in the apomorphine response (or challenge) test for assessment of dopamine-induced motor response in patients thought to have PD, or in establishing the optimal tolerated dose of apomorphine in patients already known to have PD. Also discussed is the management of potential adverse events with subcutaneous administration of apomorphine, the majority of which are mild and easily managed in practice. The importance of a multidisciplinary PD team in the optimal management of PD patients is now recognized, in particular the role of the specialist PD nurse.Keywords
This publication has 84 references indexed in Scilit:
- Parkinson’s disease: The non-motor issuesParkinsonism & Related Disorders, 2011
- Impulse control disorders in Parkinson's diseaseCurrent Opinion in Neurology, 2011
- Domperidone and Ventricular Arrhythmia or Sudden Cardiac DeathDrug Safety, 2010
- Dopamine and impulse control disorders in Parkinson's diseaseAnnals of Neurology, 2009
- Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single doseJournal of the Neurological Sciences, 2007
- Pharmacokinetic Optimisation in the Treatment of Parkinson???s DiseaseClinical Pharmacokinetics, 2006
- Subcutaneous ApomorphineDrugs & Aging, 2004
- Apomorphine‐induced penile erections in Parkinson's diseaseMovement Disorders, 1998
- The short-duration response to apomorphine: Implications for the mechanism of dopaminergic effects in parkinsonismAnnals of Neurology, 1990
- III. Researches into the chemical constitution of the opium bases. Part I.—On the action of hydrochloric acid on morphiaProceedings of the Royal Society of London, 1869